Logo image of OPK

OPKO HEALTH INC (OPK) Stock Fundamental Analysis

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.68  +0.01 (+0.6%)

After market: 1.6894 +0.01 (+0.56%)

Fundamental Rating

2

Overall OPK gets a fundamental rating of 2 out of 10. We evaluated OPK against 108 industry peers in the Health Care Providers & Services industry. The financial health of OPK is average, but there are quite some concerns on its profitability. OPK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPK had negative earnings in the past year.
In the past year OPK has reported a negative cash flow from operations.
OPK had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPK reported negative operating cash flow in multiple years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

OPK has a worse Return On Assets (-5.93%) than 65.42% of its industry peers.
OPK has a Return On Equity of -9.53%. This is comparable to the rest of the industry: OPK outperforms 42.99% of its industry peers.
Industry RankSector Rank
ROA -5.93%
ROE -9.53%
ROIC N/A
ROA(3y)-8.6%
ROA(5y)-7.64%
ROE(3y)-12.14%
ROE(5y)-10.82%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10 -15 -20

1.3 Margins

OPK has a Gross Margin of 25.10%. This is comparable to the rest of the industry: OPK outperforms 48.60% of its industry peers.
OPK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-1.1%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPK remains at a similar level compared to 1 year ago.
OPK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OPK has a worse debt to assets ratio.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

OPK has an Altman-Z score of -0.40. This is a bad value and indicates that OPK is not financially healthy and even has some risk of bankruptcy.
OPK's Altman-Z score of -0.40 is on the low side compared to the rest of the industry. OPK is outperformed by 79.44% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that OPK is not too dependend on debt financing.
OPK has a better Debt to Equity ratio (0.31) than 62.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACC8.03%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.97 indicates that OPK has no problem at all paying its short term obligations.
OPK has a Current ratio of 2.97. This is amongst the best in the industry. OPK outperforms 86.92% of its industry peers.
A Quick Ratio of 2.69 indicates that OPK has no problem at all paying its short term obligations.
OPK's Quick ratio of 2.69 is amongst the best of the industry. OPK outperforms 85.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.69
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

OPK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.51%.
OPK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.94%.
OPK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-15.58%
Revenue growth 5Y-2.7%
Sales Q2Q%-2.8%

3.2 Future

The Earnings Per Share is expected to grow by 14.31% on average over the next years. This is quite good.
The Revenue is expected to decrease by -5.11% on average over the next years.
EPS Next Y24.48%
EPS Next 2Y-9.73%
EPS Next 3Y14.31%
EPS Next 5YN/A
Revenue Next Year-20.28%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.11%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as OPK's earnings are expected to grow with 14.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.73%
EPS Next 3Y14.31%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (2/21/2025, 8:00:02 PM)

After market: 1.6894 +0.01 (+0.56%)

1.68

+0.01 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners29.22%
Inst Owner Change4.39%
Ins Owners6.21%
Ins Owner Change0%
Market Cap1.15B
Analysts86
Price Target4.04 (140.48%)
Short Float %28.55%
Short Ratio27.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.05%
Min EPS beat(2)4.52%
Max EPS beat(2)89.58%
EPS beat(4)2
Avg EPS beat(4)16.94%
Min EPS beat(4)-25.07%
Max EPS beat(4)89.58%
EPS beat(8)5
Avg EPS beat(8)25.12%
EPS beat(12)5
Avg EPS beat(12)-178.95%
EPS beat(16)8
Avg EPS beat(16)-136.34%
Revenue beat(2)0
Avg Revenue beat(2)-3.95%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-2.6%
Revenue beat(4)1
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)1.44%
Revenue beat(8)5
Avg Revenue beat(8)6.19%
Revenue beat(12)6
Avg Revenue beat(12)4.9%
Revenue beat(16)9
Avg Revenue beat(16)6.3%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-16.66%
EPS NQ rev (3m)-16.66%
EPS NY rev (1m)0%
EPS NY rev (3m)39.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.61
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 36.8
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.04
BVpS2.06
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.93%
ROE -9.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.1%
FCFM N/A
ROA(3y)-8.6%
ROA(5y)-7.64%
ROE(3y)-12.14%
ROE(5y)-10.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-1.1%
F-Score2
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.54%
Cap/Sales 3.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.69
Altman-Z -0.4
F-Score2
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)26.33%
Cap/Depr(5y)26.4%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y24.48%
EPS Next 2Y-9.73%
EPS Next 3Y14.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-15.58%
Revenue growth 5Y-2.7%
Sales Q2Q%-2.8%
Revenue Next Year-20.28%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.11%
Revenue Next 5YN/A
EBIT growth 1Y-111.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.53%
EBIT Next 3Y31.61%
EBIT Next 5YN/A
FCF growth 1Y-112.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-155.96%
OCF growth 3YN/A
OCF growth 5YN/A